Roots Analysis has done a detailed study on Biologics
Fill / Finish Services Market, 2019-2030., covering key aspects of the industry’s evolution and
identifying potential future growth opportunities.
To order this 480+ page report, which features 237 figures
and 267 tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
Key Market Insights
§
§
§
§
§
§
§
§
§
§
For more information, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biologics
3.3. Need for Outsourcing
Biologics-related Operations
3.4. Introduction to Contract
Manufacturing
3.5. Commonly Outsourced Operations in the
Biopharmaceutical Industry
3.5.1. Biologics Fill / Finish Operations
3.6. Basic Guidelines for Selecting a Fill
/ Finish Service Provider
3.7. Advantages of Outsourcing Fill / Finish
Services
3.8. Risks and Challenges of Outsourcing
Fill / Finish Operations
4. COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Biologics Fill / Finish Service
Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Fill / Finish
Facilities
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Additional Services Offered
4.2.7. Analysis by Scale of Operation
4.2.8. Analysis by Type of Biologics Filled
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Input Parameters
5.4. Competitiveness Analysis: Biologics
Fill / Finish Service Providers in North America
5.4.1. Companies Offering Fill / Finish
Services for Ampoules
5.4.2. Companies Offering Fill / Finish
Services for Cartridges
5.4.3. Companies Offering Fill / Finish
Services for Syringes
5.4.4. Companies Offering Fill / Finish
Services for Vials
5.5. Competitiveness Analysis: Fill /
Finish Service Providers in Europe
5.5.1. Companies Offering Fill / Finish
Services for Ampoules
5.5.2. Companies Offering Fill / Finish
Services for Cartridges
5.5.3. Companies Offering Fill / Finish
Services for Syringes
5.5.4. Companies Offering Fill / Finish
Services for Vials
5.6. Competitiveness Analysis: Fill /
Finish Service Providers of Asia-Pacific
5.6.1. Companies Offering Fill / Finish
Services for Ampoules
5.6.2. Companies Offering Fill / Finish
Services for Cartridges
5.6.3. Companies Offering Fill / Finish
Services for Syringes
5.6.4. Companies Offering Fill / Finish
Services for Vials
6. BIOLOGICS FILL / FINISH SERVICE
PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
6.1. Chapter Overview
6.2. Advanced BioScience Laboratories
(ABL)
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments
6.2.4. Future Outlook
6.3. Albany Molecular Research (AMRI)
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Financial Information
6.3.4. Recent Developments
6.3.5. Future Outlook
6.4. BioPharma Solutions
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Financial Information
6.4.4. Recent Developments
6.4.5. Future Outlook
6.5. BioReliance
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Financial Information
6.5.4. Recent Developments
6.5.5. Future Outlook
6.6. Emergent BioSolutions
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Financial Information
6.6.4. Recent Developments
6.6.5. Future Outlook
6.7. Patheon
6.7.1. Company Overview
6.7.2. Services Portfolio
6.7.3. Financial Information
6.7.4. Recent Developments
6.7.5. Future Outlook
7. BIOLOGICS FILL / FINISH SERVICE
PROVIDERS IN EUROPE: COMPANY PROFILES
7.1. Chapter Overview
7.2. Boehringer Ingelheim BioXcellence
7.2.1. Company Overview
7.2.2. Service Portfolio
7.2.3. Financial Information
7.2.4. Recent Developments
7.2.5. Future Outlook
7.3. IDT Biologika
7.3.1. Company Overview
7.3.2. Service Portfolio
7.3.3. Recent Developments
7.3.4. Future Outlook
7.4. Lonza
7.4.1. Company Overview
7.4.2. Service Portfolio
7.4.3. Financial Information
7.4.4. Recent Developments
7.4.5. Future Outlook
7.5. Recipharm
7.5.1. Company Overview
7.5.2. Service Portfolio
7.5.3. Financial Information
7.5.3. Recent Developments
7.5.4. Future Outlook
7.6. Vetter Pharma
7.6.1. Company Overview
7.6.2. Service Portfolio
7.6.3. Recent Developments
7.6.4. Future Outlook
8. BIOLOGICS FILL / FINISH SERVICE
PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
8.1. Chapter Overview
8.2. Biocon
8.2.1. Company Overview
8.2.2. Service Portfolio
8.2.3. Financial Information
8.2.4. Recent Developments
8.2.5. Future Outlook
8.3. ChemPartner
8.3.1. Company Overview
8.3.2. Service Portfolio
8.3.3. Recent Developments
8.3.4. Future Outlook
8.4. LuinaBio
8.4.1. Company Overview
8.4.2. Service Portfolio
8.4.3. Recent Developments
8.4.4. Future Outlook
8.5. Mycenax Biotech
8.5.1. Company Overview
8.5.2. Service Portfolio
8.5.3. Financial Information
8.5.3. Recent Developments
8.5.4. Future Outlook
8.6. Wuxi Biologics
8.6.1. Company Overview
8.6.2. Service Portfolio
8.6.3. Financial Information
8.6.4. Recent Developments
8.6.4. Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Biologics Fill / Finish Service
Providers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Type of Service
9.3.4. Analysis by Scale of Operation
9.3.5. Analysis by Type of Biologic
9.3.6. Analysis by Geographical Location
9.3.7. Most Active Players: Analysis by Number
of Partnerships
9.3.8. Service Alliances and Supply Agreements:
Analysis by Type of Service
9.3.9. Acquisitions and Mergers: Analysis by
Type of Service
10. RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Biologics Fill / Finish Service
Providers: Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Type of Packaging
10.2.4. Analysis by Type of Service
10.2.5. Analysis by Type of Biologic
10.2.6. Analysis by Type of Biologic and Scale of
Operation
10.2.7. Analysis by Geographical Location
10.2.8. Most Active Players: Analysis by Type of
Service and Type of Biologic
10.2.9. Expansions in North America: Analysis by
Type of Service and Type of
Biologic
10.2.10. Expansions in Europe: Analysis by Type of
Service and Type of Biologic
10.2.11. Expansions in Asia-Pacific: Analysis by Type
of Service and Type of Biologic
11. CAPACITY ANALYSIS
11.1. Chapter
Overview
11.2. Assumptions and Methodology
11.3. Global
Installed Fill / Finish Capacity (by Number of Units)
11.3.1. Analysis by Type of Packaging
11.3.2. Analysis by Size of Manufacturer
11.3.3. Analysis by Scale of Operation
11.3.4. Analysis by Location of Headquarters
11.3.5. Analysis by Location of Fill / Finish
Facilities
11.4. Global
Installed Fill / Finish Capacity (by Volume)
11.4.1. Analysis by Type of Packaging
11.4.2. Analysis by Size of Manufacturer
11.4.3. Analysis by Scale of Operation
11.4.4. Analysis by Location of Headquarters
11.4.5. Analysis by Location of Fill / Finish
Facilities
11.5. Global
Installed Fill / Finish Capacity for Ampoules (by Number of Units)
11.5.1 Analysis by Size of Manufacturer
11.5.2 Analysis by Scale of Operation
11.5.3. Analysis by Location of Headquarters
11.5.4 Analysis by Location of Fill / Finish
Facilities
11.6. Global
Installed Fill / Finish Capacity for Ampoules (by Volume)
11.6.1. Analysis by Size of Manufacturer
11.6.2. Analysis by Scale of Operation
11.6.3. Analysis by Location of Headquarters
11.6.4. Analysis by Location of Fill / Finish
Facilities
11.7. Global
Installed Fill / Finish Capacity for Cartridges (by Number of Units)
11.7.1. Analysis by Size of Manufacturer
11.7.2. Analysis by Scale of Operation
11.7.3. Analysis by Location of Headquarters
11.7.4. Analysis by Location of Fill / Finish
Facilities
11.8. Global
Installed Fill / Finish Capacity for Cartridges (by Volume)
11.8.1. Analysis by Size of Manufacturer
11.8.2. Analysis by Scale of Operation
11.8.3. Analysis by Location of Headquarters
11.8.4. Analysis by Location of Fill / Finish
Facilities
11.9. Global
Installed Fill / Finish Capacity for Syringes (by Number of Units)
11.9.1 Analysis by Size of Manufacturer
11.9.2 Analysis by Scale of Operation
11.9.3. Analysis by Location of Headquarters
11.9.4 Analysis by Location of Fill / Finish
Facilities
11.10. Global
Installed Fill / Finish Capacity for Syringes (by Volume)
11.10.1. Analysis by Size of Manufacturer
11.10.2. Analysis by Scale of Operation
11.10.3. Analysis by Location of Headquarters
11.10.4. Analysis by Location of Fill / Finish
Facilities
11.11. Global
Installed Fill / Finish Capacity for Vials (by Number of Units)
11.11.1 Analysis by Size of Manufacturer
11.11.2 Analysis by Scale of Operation
11.11.3. Analysis by Location of Headquarters
11.11.4. Analysis by Location of Fill / Finish
Facilities
11.12. Global
Installed Fill / Finish Capacity for Vials (by Volume)
11.12.1. Analysis by Size of Manufacturer
11.12.2. Analysis by Scale of Operation
11.12.3. Analysis by Location of Headquarters
11.12.4. Analysis by Location of Fill / Finish
Facilities
11.13. Conclusion
12. DEMAND ANALYSIS
12.1. Chapter
Overview
12.2. Assumptions and Methodology
12.3. Global
Demand for Biologics Fill / Finish Services
12.3.1. Analysis by Type of Packaging
12.3.2. Analysis by Type of Biologic
12.3.3. Analysis by Therapeutic Area
12.3.4. Analysis by Geographical Location
12.4. Demand and Supply Analysis
13. BIOLOGICS MANUFACTURING AND FILL /
FINISH: KEY PERFORMANCE INDICATORS
13.1. Chapter Overview
13.2. Biologics Manufacturing and Fill /
Finish: Types of Key Performance Indicators
13.2.1. Financial Indicators
13.2.1.1. Big Pharma Perspective
13.2.1.2. Contract Manufacturers’ Perspective
13.2.2. Process and Capability Indicators
13.2.2.1. Big Pharma Perspective
13.2.2.2. Contract Manufacturers’ Perspective
13.2.3. Market Reputation Indicators
13.2.3.1. Big Pharma Perspective
13.2.3.2. Contract Manufacturers’ Perspective
13.2.4. Other Important Performance Indicators
13.3.5. Conclusion
14. MARKET SIZING AND OPPORTUNITY
ANALYSIS
14.1. Chapter Overview
14.2. Forecast Methodology
14.3. Overall Biologics Fill / Finish Services
Market, 2019-2030
14.3.1. Biologics Fill / Finish Services Market,
2019-2030: Distribution by Type of Packaging
14.3.2. Biologics Fill / Finish Services Market,
2019-2030: Distribution by Scale of Operation
14.3.3. Biologics Fill / Finish Services Market,
2019-2030: Distribution by Type of Biologic
14.3.4. Biologics Fill / Finish Services Market,
2019-2030: Distribution by Therapeutic Area
14.3.5. Biologics Fill / Finish Services Market,
2019-2030: Distribution by Geographical Region
14.3.5.1 Biologics Fill / Finish Services Market in North
America, 2019-2030: Distribution by Countries
14.3.5.2. Biologics Fill / Finish Services Market in
North America, 2019-2030: Distribution by Type of Packaging
14.3.5.3. Biologics Fill / Finish Services Market in
North America, 2019-2030: Distribution by Scale of Operation
14.3.5.4. Biologics Fill / Finish Services Market in
North America, 2019-2030: Distribution by Type of Biologic
14.3.5.5. Biologics Fill / Finish Services Market in
North America, 2019-2030: Distribution by Therapeutic Area
14.3.5.6. Biologics Fill / Finish Services Market in
Europe, 2019-2030: Distribution by Countries
14.3.5.7. Biologics Fill / Finish Services Market in
Europe, 2019-2030: Distribution by Type of Packaging
14.3.5.8. Biologics Fill / Finish Services Market in
Europe, 2019-2030: Distribution by Scale of Operation
14.3.5.9. Biologics Fill / Finish Services Market in
Europe, 2019-2030: Distribution by Type of Biologic
14.3.5.10. Biologics Fill / Finish Services Market in
Europe, 2019-2030: Distribution by Therapeutic Area
14.3.5.11. Biologics Fill / Finish Services Market in
Asia Pacific, 2019-2030: Distribution by Countries
14.3.5.12. Biologics Fill / Finish Services Market in
Asia Pacific, 2019-2030: Distribution by Type of Packaging
14.3.5.13. Biologics Fill / Finish Services Market in Asia
Pacific, 2019-2030: Distribution by Scale of Operation
14.3.5.14. Biologics Fill / Finish Services Market in
Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.3.5.15. Biologics Fill / Finish Services Market in Asia
Pacific, 2019-2030: Distribution by Therapeutic Area
14.4. Biologics Fill / Finish Services Market
for Ampoules, 2019-2030
14.4.2. Biologics Fill / Finish Services Market for
Ampoules, 2019-2030: Distribution by Scale of Operation
14.4.2. Biologics Fill / Finish Services Market for
Ampoules, 2019-2030: Distribution by Type of Biologic
14.4.3. Biologics Fill / Finish Services Market for
Ampoules, 2019-2030: Distribution by Therapeutic Area
14.4.4. Biologics Fill / Finish Services Market for
Ampoules, 2019-2030: Distribution by Geographical Region
14.4.4.1. Biologics Fill / Finish Services Market for
Ampoules in North America, 2019-2030: Distribution by Scale of Operation
14.4.4.2. Biologics Fill / Finish Services Market for
Ampoules in North America, 2019-2030: Distribution by Type of Biologic
14.4.4.3. Biologics Fill / Finish Services Market for
Ampoules in North America, 2019-2030: Distribution by Therapeutic Area
14.4.4.4. Biologics Fill / Finish Services Market for
Ampoules in Europe, 2019-2030: Distribution by Scale of Operation
14.4.4.5. Biologics Fill / Finish Services Market for
Ampoules in Europe, 2019-2030: Distribution by Type of Biologic
14.4.4.6. Biologics Fill / Finish Services Market for
Ampoules in Europe, 2019-2030: Distribution by Therapeutic Area
14.4.4.7. Biologics Fill / Finish Services Market for
Ampoules in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.4.4.8. Biologics Fill / Finish Services Market for
Ampoules in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.4.4.9. Biologics Fill / Finish Services Market for
Ampoules in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.5. Biologics Fill / Finish Services Market
for Cartridges, 2019-2030
14.5.1. Biologics Fill / Finish Services Market for
Cartridges, 2019-2030: Distribution by Scale of Operation
14.5.2. Biologics Fill / Finish Services Market for
Cartridges, 2019-2030: Distribution by Type of Biologic
14.5.3. Biologics Fill / Finish Services Market for
Cartridges, 2019-2030: Distribution by Therapeutic Area
14.5.4. Biologics Fill / Finish Services Market for
Cartridges, 2019-2030: Distribution by Geographical Region
14.5.4.1. Biologics Fill / Finish Services Market for
Cartridges in North America, 2019-2030: Distribution by Scale of Operation
14.5.4.2. Biologics Fill / Finish Services Market for
Cartridges in North America, 2019-2030: Distribution by Type of Biologic
14.5.4.3. Biologics Fill / Finish Services Market for
Cartridges in North America, 2019-2030: Distribution by Therapeutic Area
14.5.4.4. Biologics Fill / Finish Services Market for
Cartridges in Europe, 2019-2030: Distribution by Scale of Operation
14.5.4.5. Biologics Fill / Finish Services Market for
Cartridges in Europe, 2019-2030: Distribution by Type of Biologic
14.5.4.6. Biologics Fill / Finish Services Market for
Cartridges in Europe, 2019-2030: Distribution by Therapeutic Area
14.5.4.7. Biologics Fill / Finish Services Market for
Cartridges in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.5.4.8. Biologics Fill / Finish Services Market for
Cartridges in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.5.4.9. Biologics Fill / Finish Services Market for
Cartridges in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.6. Biologics Fill / Finish Services Market
for Syringes, 2019-2030
14.6.1. Biologics Fill / Finish Services Market for
Syringes, 2019-2030: Distribution by Scale of Operation
14.6.2. Biologics Fill / Finish Services Market for
Syringes, 2019-2030: Distribution by Type of Biologic
14.6.3. Biologics Fill / Finish Services Market for
Syringes, 2019-2030: Distribution by Therapeutic Area
14.6.4. Biologics Fill / Finish Services Market for
Syringes, 2019-2030: Distribution by Geographical Region
14.6.4.1. Biologics Fill / Finish Services Market for
Syringes in North America, 2019-2030: Distribution by Scale of Operation
14.6.4.2. Biologics Fill / Finish Services Market for
Syringes in North America, 2019-2030: Distribution by Type of Biologic
14.6.4.3. Biologics Fill / Finish Services Market for
Syringes in North America, 2019-2030: Distribution by Therapeutic Area
14.6.4.4. Biologics Fill / Finish Services Market for
Syringes in Europe, 2019-2030: Distribution by Scale of Operation
14.6.4.5. Biologics Fill / Finish Services Market for
Syringes in Europe, 2019-2030: Distribution by Type of Biologic
14.6.4.6. Biologics Fill / Finish Services Market for
Syringes in Europe, 2019-2030: Distribution by Therapeutic Area
14.6.4.7. Biologics Fill / Finish Services Market for
Syringes in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.6.4.8. Biologics Fill / Finish Services Market for
Syringes in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.6.4.9. Biologics Fill / Finish Services Market for
Syringes in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.7. Biologics Fill / Finish Services Market
for Vials, 2019-2030
14.7.1. Biologics Fill / Finish Services Market for
Vials, 2019-2030: Distribution by Scale of Operation
14.7.2. Biologics Fill / Finish Services Market for
Vials, 2019-2030: Distribution by Type of Biologic
14.7.3. Biologics Fill / Finish Services Market for
Vials, 2019-2030: Distribution by Therapeutic Area
14.7.4. Biologics Fill / Finish Services Market for
Vials, 2019-2030: Distribution by Geographical Region
14.7.4.1. Biologics Fill / Finish Services Market for
Vials in North America, 2019-2030: Distribution by Scale of Operation
14.7.4.2. Biologics Fill / Finish Services Market for
Vials in North America, 2019-2030: Distribution by Type of Biologic
14.7.4.3. Biologics Fill / Finish Services Market for
Vials in North America, 2019-2030: Distribution by Therapeutic Area
14.7.4.4. Biologics Fill / Finish Services Market for
Vials in Europe, 2019-2030: Distribution by Scale of Operation
14.7.4.5. Biologics Fill / Finish Services Market for
Vials in Europe, 2019-2030: Distribution by Type of Biologic
14.7.4.6. Biologics Fill / Finish Services Market for
Vials in Europe, 2019-2030: Distribution by Therapeutic Area
14.7.4.7. Biologics Fill / Finish Services Market for
Vials in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.7.4.8. Biologics Fill / Finish Services Market for
Vials in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.7.4.9. Biologics Fill / Finish Services Market for
Vials in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
15. FUTURE GROWTH OPPORTUNITIES
15.1. Chapter Overview
15.2. Growing Biopharmaceutical Pipeline
15.3. Increase in Outsourcing Fill / Finish
Activities
15.4. Rising Focus on Self-Administration
15.5. Advances in Aseptic Fill / Finish
Technologies
15.6. Growing Opportunities in the
Asia-Pacific Region
16. CASE STUDY: ROBOTIC SYSTEMS IN FILL /
FINISH OPERATIONS
16.1. Chapter Overview
16.2. Contract Service Providers: List of
Fill / Finish Equipment
16.3. Role of Robotic Systems in Fill / Finish Operations
16.3.1. Types of Robots Used in Pharmaceutical
Operations
16.3.2. Key Considerations for Selecting a Robotic
System
16.3.3. Advantages of Robotic Systems
16.3.4. Disadvantages of Robotic Systems
16.4. Companies Providing Robots for Use in
the Pharmaceutical Industry
16.5. Concluding Remarks
17. CASE STUDY: READY-TO-USE PACKAGING
COMPONENTS IN ASEPTIC FILL / FINISH OPERATIONS
17.1. Chapter Overview
17.2. Role of Ready-to-Use Packaging
Components in Aseptic Fill / Finish Operations
17.2.1. Advantages of Ready-to-Use Packaging
Components
17.2.2. Disadvantages of Ready-to-Use Packaging
Components
17.3. Companies Providing Ready-to-Use
Packaging Components
17.4. Concluding Remarks
18. CONCLUDING REMARKS
18.1. Chapter Overview
18.2. Key Takeaways
19. INTERVIEW TRANSCRIPTS
19.1 Chapter Overview
19.2 HALIX
19.2.1 Interview Transcript: Jos Vergeest,
International Business Developer
19.3 IDT Biologika
19.3.1. Interview Transcript: Gregor Kawaletz,
Chief Commercial Officer
19.4 oncomed manufacturing
19.4.1 Interview Transcript: Ales Sima,
Business Development Manager
19.5. Syngene
19.5.1 Interview Transcript: Purushottam
Singnurkar, Research Director and Head of Formulation Development
20. APPENDIX 1: TABULATED DATA
21. APPENDIX 2: LIST OF COMPANIES AND
ORGANIZATIONS
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415